ADMA BIOLOGICS, INC. Cost of Goods Sold (Deprecated 2018-01-31)
ADMA BIOLOGICS, INC. (ADMA) reported Cost of Goods Sold (Deprecated 2018-01-31) of $12.24 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-05-14
- ADMA BIOLOGICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $12.24M, a 657.46% increase year-over-year.
- ADMA BIOLOGICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $11.92M, a 491.90% increase year-over-year.
- ADMA BIOLOGICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $11.29M, a 550.50% increase year-over-year.
- ADMA BIOLOGICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $4.33M, a 222.41% increase year-over-year.
- ADMA BIOLOGICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $29.16M, a 358.50% increase from fiscal 2016.
- ADMA BIOLOGICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $6.36M, a 47.53% increase from fiscal 2015.
- ADMA BIOLOGICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $4.31M, a 15.21% increase from fiscal 2014.
- ADMA BIOLOGICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $3.74M, a 84.95% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $12.24M 10-Q · filed 2018-05-14 | $24.17M derived: sum of 2 quarters · filed 2018-05-14 | $35.46M derived: sum of 3 quarters · filed 2018-05-14 | $39.79M derived: sum of 4 quarters · filed 2018-05-14 |
| 2017-12-31 | $11.92M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $23.21M derived: sum of 2 quarters · filed 2018-03-29 | $27.55M derived: sum of 3 quarters · filed 2018-03-29 | $29.16M 10-K · filed 2018-03-29 |
| 2017-09-30 | $11.29M 10-Q · filed 2017-11-03 | $15.63M derived: sum of 2 quarters · filed 2017-11-03 | $17.24M 10-Q · filed 2017-11-03 | $19.26M derived: sum of 4 quarters · filed 2018-05-14 |
| 2017-06-30 | $4.33M 10-Q · filed 2017-08-11 | $5.95M 10-Q · filed 2017-08-11 | $7.96M derived: sum of 3 quarters · filed 2018-05-14 | $9.70M derived: sum of 4 quarters · filed 2018-05-14 |
| 2017-03-31 | $1.62M 10-Q · filed 2018-05-14 | $3.63M derived: sum of 2 quarters · filed 2018-05-14 | $5.37M derived: sum of 3 quarters · filed 2018-05-14 | $6.71M derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $3.75M derived: sum of 2 quarters · filed 2018-03-29 | $5.09M derived: sum of 3 quarters · filed 2018-03-29 | $6.36M 10-K · filed 2018-03-29 |
| 2016-09-30 | $1.74M 10-Q · filed 2017-11-03 | $3.08M derived: sum of 2 quarters · filed 2017-11-03 | $4.35M 10-Q · filed 2017-11-03 | $5.85M derived: sum of 4 quarters · filed 2017-11-03 |
| 2016-06-30 | $1.34M 10-Q · filed 2017-08-11 | $2.61M 10-Q · filed 2017-08-11 | $4.11M derived: sum of 3 quarters · filed 2017-08-11 | $5.23M derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-03-31 | $1.27M 10-Q · filed 2017-05-12 | $2.77M derived: sum of 2 quarters · filed 2017-05-12 | $3.88M derived: sum of 3 quarters · filed 2017-05-12 | $4.67M derived: sum of 4 quarters · filed 2017-05-12 |
| 2015-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $2.62M derived: sum of 2 quarters · filed 2017-02-24 | $3.40M derived: sum of 3 quarters · filed 2017-02-24 | $4.31M 10-K · filed 2017-02-24 |
| 2015-09-30 | $1.11M 10-Q · filed 2016-11-10 | $1.90M derived: sum of 2 quarters · filed 2016-11-10 | $2.81M 10-Q · filed 2016-11-10 | $3.77M derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $786.32K 10-Q · filed 2016-08-12 | $1.70M 10-Q · filed 2016-08-12 | $2.65M derived: sum of 3 quarters · filed 2016-08-12 | $3.52M derived: sum of 4 quarters · filed 2016-08-12 |
| 2015-03-31 | $909.63K 10-Q · filed 2016-05-13 | $1.87M derived: sum of 2 quarters · filed 2016-05-13 | $2.73M derived: sum of 3 quarters · filed 2016-05-13 | $3.67M derived: sum of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | $956.84K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $1.82M derived: sum of 2 quarters · filed 2016-03-23 | $2.77M derived: sum of 3 quarters · filed 2016-03-23 | $3.74M 10-K · filed 2016-03-23 |
| 2014-09-30 | $867.68K 10-Q · filed 2015-11-10 | $1.81M derived: sum of 2 quarters · filed 2015-11-10 | $2.79M 10-Q · filed 2015-11-10 | $3.07M derived: sum of 4 quarters · filed 2015-11-10 |
| 2014-06-30 | $940.82K 10-Q · filed 2015-08-11 | $1.92M 10-Q · filed 2015-08-11 | $2.20M derived: sum of 3 quarters · filed 2015-08-11 | $2.93M derived: sum of 4 quarters · filed 2015-08-11 |
| 2014-03-31 | $977.03K 10-Q · filed 2015-05-12 | $1.26M derived: sum of 2 quarters · filed 2015-05-12 | $1.99M derived: sum of 3 quarters · filed 2015-05-12 | $2.47M derived: sum of 4 quarters · filed 2015-05-12 |
| 2013-12-31 | $282.39K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $1.01M derived: sum of 2 quarters · filed 2015-03-09 | $1.49M derived: sum of 3 quarters · filed 2015-03-09 | $2.02M 10-K · filed 2015-03-09 |
| 2013-09-30 | $726.25K 10-Q · filed 2014-11-10 | $1.21M derived: sum of 2 quarters · filed 2014-11-10 | $1.74M 10-Q · filed 2014-11-10 | $2.12M derived: sum of 4 quarters · filed 2014-11-10 |
| 2013-06-30 | $485.76K 10-Q · filed 2014-08-11 | $1.01M 10-Q · filed 2014-08-11 | $1.40M derived: sum of 3 quarters · filed 2014-08-11 | $1.54M derived: sum of 4 quarters · filed 2014-08-11 |
| 2013-03-31 | $529.05K 10-Q · filed 2014-05-12 | $909.34K derived: sum of 2 quarters · filed 2014-05-12 | $1.05M derived: sum of 3 quarters · filed 2014-05-12 | $1.20M derived: sum of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | $380.30K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $524.99K derived: sum of 2 quarters · filed 2014-03-28 | $666.86K derived: sum of 3 quarters · filed 2014-03-28 | $669.06K 10-K · filed 2014-03-28 |
| 2012-09-30 | $144.69K 10-Q · filed 2013-11-12 | $286.56K derived: sum of 2 quarters · filed 2013-11-12 | $288.76K 10-Q · filed 2013-11-12 | $496.33K derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-06-30 | $141.87K 10-Q · filed 2013-08-12 | $144.07K 10-Q · filed 2013-08-12 | $351.64K derived: sum of 3 quarters · filed 2013-08-12 | $351.64K derived: sum of 4 quarters · filed 2013-08-12 |
| 2012-03-31 | $2.20K 10-Q · filed 2013-05-14 | $209.77K derived: sum of 2 quarters · filed 2013-05-14 | $209.77K derived: sum of 3 quarters · filed 2013-05-14 | |
| 2011-12-31 | $207.57K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-06 | $207.57K derived: sum of 2 quarters · filed 2013-03-06 | $207.57K 10-K · filed 2013-03-06 | |
| 2011-09-30 | $0.00 10-Q · filed 2012-11-13 | $0.00 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |